Skip to main content

COMPX REPORTS FIRST QUARTER 2026 RESULTS

Dallas, Texas, May 05, 2026 (GLOBE NEWSWIRE) — CompX International Inc. (NYSE American: CIX) announced today net sales of $40.6 million for the first quarter of 2026 compared to $40.3 million in the same period of 2025. Operating income was $7.1 million in the first quarter of 2026 compared to $5.9 million in the same period of 2025. Net income was $5.9 million, or $.48 per basic and diluted common share, for the first quarter of 2026 compared to $5.1 million, or $.42 per basic and diluted common share, in the same period of 2025. First quarter 2026 net sales increased over the comparable 2025 period due to higher Marine Components sales to the industrial market partially offset by lower Security Products sales. Operating income increased in the first quarter of 2026 compared to the same period in 2025 primarily due to higher gross...

Continue reading

OMVIC Releases 2025 Annual Report Highlighting Strong Consumer Protection Results

Toronto, ON, May 05, 2026 (GLOBE NEWSWIRE) — The Ontario Motor Vehicle Industry Council (OMVIC) is pleased to share that its 2025 Annual Report has been published, highlighting a year of progress in protecting consumers and supporting registrant professionalism. Key highlights from 2025 Annual Report include:OMVIC more than doubled its proposals to revoke, refuse, or suspend registrations, rising from 34 in 2024 to 79 in 2025. This total included 26 immediate temporary suspension orders in 2025 up from the 3 temporary suspensions issued in 2024. A total of 2,332 charges were laid against dealers, salespersons, and unregistered (illegal) sellers, also known as curbsiders, resulting in $1.9 million in fines under the Provincial Offences Act. $825,552 was returned to consumers through dealer compensation or refunds. $1.5 million...

Continue reading

Eimskip: Q1 2026 financial results

Q1 2026 highlights Challenging quarter, with early signs of operational improvement. Revenue amounted to EUR 191.7 million, decreasing by EUR 9.6 million, or 4.8%, compared to the same period last year. Revenue and performance development varied across business segments.Volume in the sailing system declined by 4.5% during the quarter, while revenue decreased by only 1.4%. Excluding the impact of production disruption at Norðurál and the closure of PCC Bakki, transported volume in the sailing system increased between periods, driven by strong imports to Iceland and increased exports of seafood and salmon from Iceland and the Faroe Islands.Revenue from international freight forwarding decreased by 12.7%, despite a 6.3% increase in volume, reflecting significantly lower global freight rates. The Drewry World Container Index declined...

Continue reading

Viridien: 2026 first-quarter results

Paris (France), May 5, 2026 2026 first-quarter resultsSolid cash generation and continued deleveraging in a soft market environmentNet Cash Flow generation of $26m compared to -$20m in Q1 2025, driven by disciplined cash management and efficient receivables collectionFurther reduction in Net Debt (excluding IFRS 16) to $702m vs $735m at end-December 2025, with an additional $40.7m repaid in March on the USD-denominated bond trancheSegment revenue of $214m, reflecting a slow start to the year as anticipated, with additional uncertainty stemming from the ongoing conflict in the Middle East, impacting SMO and GEOProfitability reflecting lower revenue, with segment adjusted EBITDAs of $76mFY 2026 guidance for Net Cash Flow generation of $100m, with a seasonal profile similar to 2025, reiteratedSophie Zurquiyah, Chair and CEO...

Continue reading

NTG Nordic Transport Group publishes interim report for Q1 2026

Company announcement no. 14 – 2605 May 2026 NTG Nordic Transport Group publishes interim report for Q1 2026 The interim report for Q1 2026 is enclosed. In connection with publication of the results for Q1 2026, a conference call will be hosted on 06 May 2026 at 10:00 AM CEST. The conference call will be held in English and can be followed live via NTG’s website; investor.ntg.com. Additional information For additional information, please contact:Investor relations and press:Sebastian Rosborg,Head of Investor Relations                                     +45 42 12 80 99 Sebastian.rosborg@ntg.com ir@ntg.com|press@ntg.com   Attachments NTG interim report Q1 2026AttachmentsNTG Interim Report Q1 2026Company announcement no. 14_2026

Continue reading

Qualstar Corporation Reports First Quarter 2026 Results

CAMARILLO, Calif., May 05, 2026 (GLOBE NEWSWIRE) — Qualstar Corporation (OTC: QBAK), a trusted provider of scalable data storage and high-efficiency power solutions, today reported financial results for the quarter ended March 31, 2026. 2026 and Recent HighlightsQ1 revenues were driven by sales of our data storage products. We continue to invest in the data storage business unit to offset the decline in the power supplies segment. The recent launch of our enterprise system, the Q1000+ powered by Orion, enables us to achieve a higher average selling price and expand our total addressable market. We are benefiting from increased demand for tape-based data storage solutions, driven by their total cost of ownership advantage over competing technologies. Additionally, the current memory shortage is significantly affecting the cost...

Continue reading

WaveMaker’s Agentic AI Application Generation System Sees Strong Early Momentum Following Launch, Enterprise and Partner Trials Surging Across Industries

Rapid enterprise adoption validates WaveMaker’s architecture approach, delivering reliable, scalable applications with speed, cost efficiency and governance Dallas, TX, May 05, 2026 (GLOBE NEWSWIRE) —  WaveMaker, the leading agentic AI system for enterprise-grade web and mobile application teams, today announced significant early momentum following its February launch of its new agentic application generation system. Within weeks of opening trial sign-ups at wavemaker.ai, the company has seen strong demand from enterprise development teams across financial services, banking, energy, supply chain, and telecommunications — industries where code quality, architectural governance, and predictable costs are non-negotiable. The response validates WaveMaker’s core thesis: that enterprise development teams need more than speed from...

Continue reading

Ocugen Provides Business Update with First Quarter 2026 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ETPositive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) indicates a statistically significant (p 30% reduction in Iesion growth compared to control, with a favorable safety and tolerability profile Allows robust registrational Phase 3 trial design, a potential combined U.S./EU trial with 300 subjects, with adaptive design powered at over 95%Trial enrollment complete for OCU400 for retinitis pigmentosa (RP) and OCU410ST for Stargardt disease registration trials, and on target to complete two Biologics License Application (BLA) submissions by 2027 The closing of a private offering of $115 million aggregate principal amount ($130 million if overallotment is exercised) of 6.75% convertible senior notes due 2034, with a conversion premium of 45%,...

Continue reading

Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update

Completed enrollment of the Phase 3 APOLLO study of bitopertin in erythropoietic protoporphyria (EPP); topline data expected in Q4 2026Updated data from Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis (MF) to be shared at the American Society of Clinical Oncology (ASCO) Annual Meeting as an oral presentationProgressing ongoing Phase 2 study of DISC-3405 in polycythemia vera (PV) and Phase 1b study of DISC-3405 in sickle cell disease (SCD), with data from both studies expected in Q4 2026Strong financial position ending Q1 with approximately $730 million in cash, cash equivalents, and marketable securities, providing runway into 2029WATERTOWN, Mass., May 05, 2026 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization...

Continue reading

Sofwave Medical Reports First Quarter Fiscal 2026 Financial Results and Business Highlights

First quarter revenue of $24.4M, +46% year-over-year growth; IFRS gross margin of 75.0% First quarter usage fee revenue of $11.0M, +56% year-over-year growthIFRS and non-IFRS net income of $1.3M and $1.7M versus IFRS and non-IFRS net losses of $1.1M and $0.4M in the prior year ago periodApproximately 2,900 Sofwave systems sold to date and more than 865,000 Sofwave treatments administered since commercializationSAN CLEMENTE, Calif., May 05, 2026 (GLOBE NEWSWIRE) —  Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported financial results for the three-month period ended March 31, 2026, and recent business highlights. First Quarter 2026 Financial HighlightsFirst Quarter 2026 Revenue of $24.4M; representing 46% year-over-year growthRecurring...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.